Insights on the Vitamin D Therapy Global Market to 2029 - by Route of Administration, Purchasing Pattern, Application, Age Group and Region - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Vitamin D Therapy Market Analysis by Route of Administration, by Purchasing Pattern, by Application, Age Group and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The vitamin D therapy market size is estimated to be USD 2.6 billion in 2021 and is expected to witness a CAGR of 14.42% during the forecast period 2022-2029.
The rising knowledge of vitamin D deficiency, and the existence of a large target patient population are some of the key drivers for the market growth.
Furthermore, presence of key players and increasing geriatric population is expected to contribute the market growth. However, food fortification is expected to restrain the market growth.
- Abbott (US)
- Sanofi (France)
- GlaxoSmithKline plc (UK)
- Pfizer Inc. (US)
- Merck & Co. Inc. (US)
- Torrent Pharmaceuticals Ltd. (India)
- Novartis International AG (Switzerland)
- Alkem Laboratories (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Cadila Healthcare Ltd (India)
By Route of Administration (Revenue, USD Billion)
- Parenteral Route
- Oral Route
By Purchasing Pattern (Revenue, USD Billion)
- Prescription Drugs
- OTC Drugs
By Application (Revenue, USD Billion)
- Autoimmune Disorders
- Muscle Weakness
- Skin Diseases
By Age Group (Revenue, USD Billion)
- Senior Adults
By Region (Revenue, USD Billion)
- Rest of Europe
- South Korea
- Rest of APAC
- Rest of LATAM
Middle East & Africa
- South Africa
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/ioqlow-d-therapy?w=4
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900